findmyKOL
Clinical trialNCT06451757RecruitingPhase 3Interventional

KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases

SponsorKhondrion BVEnrollment220Maternally Inherited Diabetes and Deafness (MIDD)Mitochondrial DNA tRNALeu(UUR) m.3243A<G MutationMitochondrial DiseasesMitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Denmark
  • Rigshospitalet, University of Copenhagen

    Kopenhagen, Region Sjælland, Denmark

    Nicolai Rasmus Preisler, Dr.
    Not, yet, recruiting
France
  • Chu de Bordeaux - Hôpital Pellegrin Service Gynecologie Obstetrique

    Bordeaux, Gironde, France

    Aurelien Trimouille, Dr.
    Not, yet, recruiting
  • Groupe Hospitalier Pitie-Salpetriere - Charles-Foix Clinical Investigation Center Paris-Est

    Paris, Paris, France

    Fanny Mochel, Dr.
    Not, yet, recruiting
Germany
  • Klinikum Der Universität München Friedrich-Baur-Institut

    München, Germany

    Boriana Buechner, Dr.Thomas Klopstock, Prof. Dr.
    Recruiting
Italy
  • Fondazione Irccs Istituto Neurologico Carlo Besta

    Milan, Italy

    Costanza Lamperti, Dr.
    Recruiting
Netherlands
  • Radboud University Medical Center

    Nijmegen, Gelderland, Netherlands

    Mirian Janssen, MD, PhD
    Recruiting
United Kingdom
  • University College London Hospitals Nhs Foundation Trust National Hospital for Neurology and Neurosurgery

    London, Greater London, United Kingdom

    Robbert Pitceathly, Dr.
    Recruiting
United States
  • Massachusetts General Hospital

    Boston, Massachusetts, United States

    Amel Karaa, Dr.
    Not, yet, recruiting
  • Cleveland Clinic Neurological Institute Mellen Center

    Cleveland, Ohio, United States

    Sumit Parikh, Dr.
    Not, yet, recruiting
  • the University of Texas Health Science Center at Houston

    Houston, Texas, United States

    Mary Koenig, Dr.Sam Nicholas Russo, Dr.
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Apr 2026
Primary completion
30 Sept 2028
Completion
30 Sept 2028
Last update posted
29 Jun 2026
Registered enrollment
220
Registry id
NCT06451757

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.